| __timestamp | Soleno Therapeutics, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2917513 | 7751000 |
| Thursday, January 1, 2015 | 7878291 | 10251000 |
| Friday, January 1, 2016 | 8366794 | 9575000 |
| Sunday, January 1, 2017 | 6610381 | 10912000 |
| Monday, January 1, 2018 | 6556000 | 11049000 |
| Tuesday, January 1, 2019 | 6930000 | 11646000 |
| Wednesday, January 1, 2020 | 8758000 | 13265000 |
| Friday, January 1, 2021 | 10806000 | 25805000 |
| Saturday, January 1, 2022 | 9844000 | 35182000 |
| Sunday, January 1, 2023 | 13481000 | 94999000 |
Unleashing the power of data
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Soleno Therapeutics, Inc. and Viridian Therapeutics, Inc. have been navigating this challenge since 2014. Over the past decade, Soleno has maintained a relatively stable SG&A expense, averaging around $8.2 million annually. In contrast, Viridian's expenses have surged, peaking at nearly $95 million in 2023, a staggering 1,100% increase from 2014. This dramatic rise reflects Viridian's aggressive growth strategy, while Soleno's steadier approach suggests a focus on cost efficiency. As the biotech landscape evolves, these companies' strategies offer valuable insights into balancing growth with financial prudence. Investors and industry watchers should consider these trends when evaluating the long-term viability and strategic direction of these firms.
Breaking Down SG&A Expenses: GSK plc vs Viridian Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for argenx SE and Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Viridian Therapeutics, Inc.
Selling, General, and Administrative Costs: Bio-Techne Corporation vs Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Soleno Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Perrigo Company plc and Viridian Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for MorphoSys AG and Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Soleno Therapeutics, Inc. vs Dynavax Technologies Corporation: SG&A Expense Trends
Comparing SG&A Expenses: Soleno Therapeutics, Inc. vs MiMedx Group, Inc. Trends and Insights
Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared
Xencor, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared